Bearish Options Activity on Thermo Fisher Scientific Inc. After Worse Fundamentals

 Bearish Options Activity on Thermo Fisher Scientific Inc. After Worse Fundamentals

In today’s session Thermo Fisher Scientific Inc. (TMO) recorded an unusually high (1,451) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the December, 2016 put, expecting serious TMO decrease. With 1,451 contracts traded and 15254 open interest for the Dec, 16 contract, it seems this is a quite bearish bet. The option with symbol: TMO161216P00145000 closed last at: $2.8 or 33.3% up. About 153,527 shares traded hands. Thermo Fisher Scientific Inc. (NYSE:TMO) has declined 0.18% since April 20, 2016 and is downtrending. It has underperformed by 4.74% the S&P500.

Thermo Fisher Scientific Inc. (NYSE:TMO) Ratings Coverage

Out of 13 analysts covering Thermo Fisher Scientific (NYSE:TMO), 11 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 85% are positive. Thermo Fisher Scientific has been the topic of 27 analyst reports since July 24, 2015 according to StockzIntelligence Inc. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Mizuho on Tuesday, May 3. The rating was maintained by Stifel Nicolaus on Monday, January 11 with “Buy”. Deutsche Bank initiated Thermo Fisher Scientific Inc. (NYSE:TMO) on Thursday, January 7 with “Buy” rating. On Thursday, November 10 the stock rating was reinitiated by Leerink Swann with “Outperform”. The firm earned “Buy” rating on Friday, July 22 by BTIG Research. Barclays Capital maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Tuesday, July 19. Barclays Capital has “Overweight” rating and $175 price target. The rating was initiated by Argus Research with “Buy” on Tuesday, October 6. The stock has “Neutral” rating given by Cleveland on Friday, September 9. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Americas Conviction Buy List” rating given on Tuesday, December 8 by Goldman Sachs. JP Morgan initiated the stock with “Overweight” rating in Thursday, September 22 report.

According to Zacks Investment Research, “Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company’s four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts.”

Insitutional Activity: The institutional sentiment decreased to 0.79 in 2016 Q2. Its down 0.18, from 0.97 in 2016Q1. The ratio worsened, as 41 funds sold all Thermo Fisher Scientific Inc. shares owned while 373 reduced positions. 78 funds bought stakes while 324 increased positions. They now own 337.36 million shares or 4.63% less from 353.72 million shares in 2016Q1.
Ironsides Asset Advisors Limited Liability Corp accumulated 0.06% or 1,372 shares. Franklin Street Advisors Nc owns 24,996 shares or 0.7% of their US portfolio. Pax Ww Mgmt Ltd Llc accumulated 1.19% or 139,189 shares. Arrow last reported 0.01% of its portfolio in the stock. Kanaly Tru holds 0.02% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 612 shares. Moreover, Banque Pictet Cie has 2.34% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 593,626 shares. Moreover, Tradition Mngmt Limited Liability Corporation has 1.42% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 28,738 shares. Td Asset Management Inc has 451,630 shares for 0.12% of their US portfolio. Lawson Kroeker Inv Management Ne holds 1.12% or 22,745 shares in its portfolio. Allianz Asset Management Ag accumulated 0.06% or 728,324 shares. Williams Jones & Associate Ltd Liability Company holds 120,021 shares or 0.82% of its portfolio. Churchill holds 0.29% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 30,496 shares. Centurylink Inv Mgmt has invested 0.43% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Raymond James Svcs Advsr accumulated 28,400 shares or 0.04% of the stock. Pictet Asset Limited has invested 1.14% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO).

Insider Transactions: Since May 24, 2016, the stock had 0 buys, and 17 selling transactions for $37.48 million net activity. Another trade for 28,797 shares valued at $4.35M was made by CASPER MARC N on Friday, September 2. Shares for $495,824 were sold by Loewald Thomas W. Shine Daniel P sold $1.02M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday, June 15. On Friday, June 3 the insider MANZI JIM P sold $173,961. Shares for $1.30M were sold by Williamson Stephen. HOOGASIAN SETH H had sold 2,270 shares worth $345,676 on Monday, August 29. Shares for $10.39M were sold by WILVER PETER M on Friday, June 10.

Thermo Fisher Scientific Inc. develops, makes and sells a range of products. The company has a market cap of $56.16 billion. The Firm is a well-known provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It has a 28.9 P/E ratio. The firm operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

TMO Company Profile

Thermo Fisher Scientific Inc., incorporated on October 11, 1960, develops, makes and sells a range of products. The Firm is a well-known provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The firm operates through four divisions: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Firm serves its clients through its brands, Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services. The Thermo Scientific brand offers clients in research, diagnostics, industrial and applied markets analytical instruments, as well as laboratory equipment, software, services, consumables and reagents.

More news for Thermo Fisher Scientific Inc. (NYSE:TMO) were recently published by: Wsj.com, which released: “Thermo Fisher Scientific Lifts Outlook” on October 27, 2016. Businesswire.com‘s article titled: “Thermo Fisher Scientific Submits Premarket Approval Application to FDA for …” and published on November 14, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment